LINC00641 contributed to ALL cell apoptosis and inhibited ALL cell proliferation via sponging miR-152-3p and up-regulating ATP2A2, shedding a new insight into ALL treatment. The gene discussed is ATP2A2; the disease is acute lymphoblastic leukemia.